HBR Investment Group

HBR Investment Group is a French private holding and investment firm based in Suresnes, France. The company appears to focus on taking equity stakes in and managing investments in a range of businesses, including distressed or special-situation public companies. Public disclosures link HBR Investment Group to turnaround and investment activity in industrial companies such as Cybergun, Verney-Carron, and Boostheat, as well as life-science exposure through Neovacs. However, HBR Investment Group itself is not an operating biotech, pharmaceutical, or healthcare company and does not appear to develop therapeutic products directly. For biotech analysts, the most relevant context is that it has acted as an investor/shareholder and restructuring sponsor in certain French life-science situations rather than as a drug developer.